Literature DB >> 18096666

Tissue selectivity of the anabolic steroid, 19-nor-4-androstenediol-3beta,17beta-diol in male Sprague Dawley rats: selective stimulation of muscle mass and bone mineral density relative to prostate mass.

Stephanie T Page1, Brett T Marck, James M Tolliver, Alvin M Matsumoto.   

Abstract

Stimulation of prostate growth is a major concern with testosterone therapy in older hypogonadal men. As a result, nonsteroidal selective androgen receptor modulators with anabolic activity but less prostate stimulation are being developed. Anabolic steroids might exhibit similar tissue selectivity. We hypothesized the anabolic steroid 19-nor-4-androstenediol-3beta,17beta-diol (3beta,19-NA) would increase muscle, lean body mass (LBM), and bone mineral density (BMD) with little stimulation of prostate growth. Male Sprague Dawley rats were implanted with SILASTIC brand (Dow Corning, Midland, MI) capsules containing 3beta,19-NA (4, 8, or 16 cm), dihydrotestosterone (DHT) (8 cm), 19-nortestosterone (16 cm), or four empty capsules after undergoing either a sham operation (intact) or orchidectomy (ORX). Serum gonadotropins, measured after 4, 8, or 24 wk of treatment, were significantly lower in 3beta,19-NA-treated vs. untreated, intact, and ORX rats (P < 0.05), and testosterone was lowered by 3beta,19-NA-treatment of intact animals. LBM and BMD were assessed after 20 wk, and 4 wk later, rats were killed for levator ani muscle and prostate weights. Compared with ORX rats, 3beta,19-NA-treated rats had dose-dependent higher levator ani muscle weights, LBM, and BMD, which were similar to intact and DHT-treated rats at the highest 3beta,19-NA dose. In contrast, prostate weights in all 3beta,19-NA-treated groups were similar to ORX rats and lower than intact and DHT- and 19-nortestosterone-treated rats even at the highest 3beta,19-NA dose. In summary, 3beta,19-NA increases muscle and bone mass without significant stimulation of prostate growth, suggesting it may have some properties of a steroidal selective androgen receptor modulator. Anabolic steroids such as 3beta,19-NA should be studied further to determine their mechanisms of tissue selectivity and effects in men.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18096666      PMCID: PMC2276724          DOI: 10.1210/en.2007-0956

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  42 in total

1.  The metabolism of orally ingested 19-nor-4-androstene-3,17-dione and 19-nor-4-androstene-3,17-diol in healthy, resistance-trained men.

Authors:  C M Colker; J Antonio; D Kalman
Journal:  J Strength Cond Res       Date:  2001-02       Impact factor: 3.775

Review 2.  Perspective: nonreproductive sites of action of reproductive hormones.

Authors:  S C Manolagas; S Kousteni
Journal:  Endocrinology       Date:  2001-06       Impact factor: 4.736

3.  Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS.

Authors:  Marcel E de Gooyer; Hendrika M Oppers-Tiemissen; Dirk Leysen; Herman A M Verheul; Helenius J Kloosterboer
Journal:  Steroids       Date:  2003-03       Impact factor: 2.668

4.  Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone.

Authors:  H M Behre; S Kliesch; B Lemcke; S von Eckardstein; E Nieschlag
Journal:  Hum Reprod       Date:  2001-12       Impact factor: 6.918

5.  Cross-sectional and longitudinal analysis of age-associated changes in body composition of male Brown Norway rats: association of serum leptin levels with peripheral adiposity.

Authors:  T Wolden-Hanson; B T Marck; L Smith; A M Matsumoto
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-03       Impact factor: 6.053

6.  Effects of norandrostenedione and norandrostenediol in resistance-trained men.

Authors:  Darin van Gammeren; Darin Falk; Jose Antonio
Journal:  Nutrition       Date:  2002-09       Impact factor: 4.008

7.  Testosterone (T)-induced changes in arcuate nucleus cocaine-amphetamine-regulated transcript and NPY mRNA are attenuated in old compared to young male brown Norway rats: contribution of T to age-related changes in cocaine-amphetamine-regulated transcript and NPY gene expression.

Authors:  Elliott H Sohn; Tami Wolden-Hanson; Alvin M Matsumoto
Journal:  Endocrinology       Date:  2002-03       Impact factor: 4.736

Review 8.  Sex steroids and bone.

Authors:  S C Manolagas; S Kousteni; R L Jilka
Journal:  Recent Prog Horm Res       Date:  2002

9.  Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids.

Authors:  Stavroula Kousteni; Li Han; Jin-Ran Chen; Maria Almeida; Lilian I Plotkin; Teresita Bellido; Stavros C Manolagas
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Reversal of bone loss in mice by nongenotropic signaling of sex steroids.

Authors:  S Kousteni; J R Chen; T Bellido; L Han; A A Ali; C A O'Brien; L Plotkin; Q Fu; A T Mancino; Y Wen; A M Vertino; C C Powers; S A Stewart; R Ebert; A M Parfitt; R S Weinstein; R L Jilka; S C Manolagas
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

View more
  12 in total

Review 1.  Hormone treatment and muscle anabolism during aging: androgens.

Authors:  E Lichar Dillon; William J Durham; Randall J Urban; Melinda Sheffield-Moore
Journal:  Clin Nutr       Date:  2010-05-07       Impact factor: 7.324

2.  Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass.

Authors:  Shoshana M Bartell; Li Han; Ha-neui Kim; Sung Hoon Kim; John A Katzenellenbogen; Benita S Katzenellenbogen; Ken L Chambliss; Philip W Shaul; Paula K Roberson; Robert S Weinstein; Robert L Jilka; Maria Almeida; Stavros C Manolagas
Journal:  Mol Endocrinol       Date:  2013-02-26

3.  A study of changes in bone metabolism in cases of gender identity disorder.

Authors:  Tsuyoshi Miyajima; Yoon Taek Kim; Hiromi Oda
Journal:  J Bone Miner Metab       Date:  2012-01-07       Impact factor: 2.626

Review 4.  Estrogens and Androgens in Skeletal Physiology and Pathophysiology.

Authors:  Maria Almeida; Michaël R Laurent; Vanessa Dubois; Frank Claessens; Charles A O'Brien; Roger Bouillon; Dirk Vanderschueren; Stavros C Manolagas
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

5.  A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats.

Authors:  M Komrakova; G Büchler; K O Böker; W Lehmann; A F Schilling; P J Roch; S Taudien; D B Hoffmann; S Sehmisch
Journal:  J Endocrinol Invest       Date:  2022-07-22       Impact factor: 5.467

Review 6.  The role of estrogen and androgen receptors in bone health and disease.

Authors:  Stavros C Manolagas; Charles A O'Brien; Maria Almeida
Journal:  Nat Rev Endocrinol       Date:  2013-09-17       Impact factor: 43.330

7.  Enhanced evaluation of selective androgen receptor modulators in vivo.

Authors:  M Otto-Duessel; M He; T W Adamson; J O Jones
Journal:  Andrology       Date:  2012-08-28       Impact factor: 3.842

8.  Mechanism of action of bolandiol (19-nortestosterone-3beta,17beta-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities.

Authors:  Barbara J Attardi; Stephanie T Page; Sheri A Hild; Christopher C Coss; Alvin M Matsumoto
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-24       Impact factor: 4.292

Review 9.  Prostate tissue androgens: history and current clinical relevance.

Authors:  Leonard S Marks; Elahe A Mostaghel; Peter S Nelson
Journal:  Urology       Date:  2008-05-27       Impact factor: 2.649

Review 10.  Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and disease.

Authors:  James A Carson; Stavros C Manolagas
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.